Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
The DOI matches its Crossref record.
Abstract
The classifications of hepatocellular carcinoma (HCC) currently used are based on prognostic factors obtained from studies performed years ago when most tumors were diagnosed at advanced stages and the survival rates were substantially poor. Recent investigations have reviewed the survival of early tumors properly selected to receive radical therapies and the natural outcome of nonsurgical HCC patients. These data enable a new staging system to be proposed, the Barcelona Clinic Liver Cancer (BCLC) staging classification, that comprises four stages that select the best candidates for the best therapies currently available. Early stage (A) includes patients with asymptomatic early tumors suitable for radical therapies--resection, transplantation or percutaneous treatments. Intermediate stage (B) comprises patients with asymptomatic multinodular HCC. Advanced stage (C) includes patients with symptomatic tumors and/or an invasive tumoral pattern (vascular invasion/extrahepatic spread). Stage B and C patients may receive palliative treatments/new agents in the setting of phase II investigations or randomized controlled trials. End-stage disease (D) contain patients with extremely grim prognosis (Okuda stage III or PST 3-4) that should merely receive symptomatic treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The management of patients with HCC has improved markedly since the first BCLC classification was proposed in 1999143.”
From Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma (2024) · cites this paper as [143]
Citations
Cites
Still being checked.
Cited by
Items 701–800 of 1,005
Blanc‐Durand, P., Gucht, A. V. D., Jreige, M., Lalonde, M. N., Silva-Monteiro, M., Prior, J. O., Denys, A. L., Depeursinge, A., & Schaefer, N. G. (2017) · Oncotarget · doi:10.18632/oncotarget.23423 · Cited by 60
ALBI versus Child‐Pugh grading systems for liver function in patients with hepatocellular carcinoma
Na, S. K., Yim, S. Y., Suh, S. J., Jung, Y. K., Kim, J. H., Seo, Y. S., Yim, H. J., Yeon, J. E., Byun, K. S., & Um, S. H. (2018) · Journal of Surgical Oncology · doi:10.1002/jso.24992 · Cited by 60
Hester, C. A., Rich, N. E., Singal, A. G., & Yopp, A. C. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.7105 · Cited by 60
Lee, C., Chan, K., Lee, C., Yu, M., Lee, W., Wu, T.-J., & Chen, M. (2011) · Asian Journal of Surgery · doi:10.1016/s1015-9584(11)60020-1 · Cited by 60
UK guidelines for management of acute pancreatitis: is it time to change?
Gurusamy, K. S., Farouk, M., & Tweedie, J. H. (2005) · Gut · doi:10.1136/gut.2005.071076 · Cited by 60
Treatment of hepatocellular carcinoma
Blum, H. E. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.11.008 · Cited by 60
Byun, H. K., Kim, H. J., Im, Y. R., Kim, D. Y., Han, K., & Seong, J. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.12.025 · Cited by 59
The intermediate hepatocellular carcinoma stage: Should treatment be expanded?
Piscaglia, F., & Bolondi, L. (2010) · Digestive and Liver Disease · doi:10.1016/s1590-8658(10)60514-2 · Cited by 59
Golfieri, R., Garzillo, G., Ascanio, S., & Renzulli, M. (2014) · Digestive Diseases · doi:10.1159/000368002 · Cited by 59
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly
Pignata, S., Gallo, C., Daniele, B., Elba, S., Giorgio, A., Capuano, G., Adinolfi, L. E., de Sio, I., Izzo, F., Farinati, F., et al. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.01.002 · Cited by 59
Early diagnosis and treatment of hepatocellular carcinoma
Llovet, J. M., & Bruix, J. (2000) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2000.0143 · Cited by 59
Self-citationPredicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers?
Pardi, D. S., & Sandborn, W. J. (2005) · Gut · doi:10.1136/gut.2004.048850 · Cited by 59
Arslanoğlu, A., Seyal, A. R., Sodagari, F., Sahin, A., Miller, F. H., Salem, R., & Yaghmai, V. (2016) · American Journal of Roentgenology · doi:10.2214/ajr.15.15490 · Cited by 58
Huang, C., Zhu, X., Ji, Y., Ding, G., Shi, G., Shen, Y., Zhou, J., Fan, J., & Sun, H. (2017) · BMC Cancer · doi:10.1186/s12885-017-3050-x · Cited by 58
Liu, C., Li, T. X., He, J., & Shao, H. (2020) · Diagnostic and Interventional Radiology · doi:10.5152/dir.2020.19615 · Cited by 58
Ando, Y., Kawaoka, T., Amioka, K., Naruto, K., Ogawa, Y., Yoshikawa, Y., Kikukawa, C., Kosaka, Y., Uchikawa, S., Morio, K., et al. (2021) · Oncology · doi:10.1159/000515865 · Cited by 58
Beumer, B. R., Buettner, S., Galjart, B., van Vugt, J. L. A., de Man, R. A., IJzermans, J. N. M., & Koerkamp, B. G. (2021) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2021.09.012 · Cited by 58
Hwang, S., Lee, Y. J., Kim, K., Ahn, C., Moon, D., Ha, T., Song, G., Jung, D., & Lee, S. (2015) · World Journal of Surgery · doi:10.1007/s00268-015-3129-y · Cited by 58
Chung, H., Kudo, M., Takahashi, S., Hagiwara, S., Sakaguchi, Y., Inoue, T., Minami, Y., Ueshima, K., Fukunaga, T., & Matsunaga, T. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05075.x · Cited by 58
Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients
Cucchetti, A., Cescon, M., Trevisani, F., & Pinna, A. D. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i44.6398 · Cited by 57
Chapiro, J., Durán, R., Lin, M., Schernthaner, R. E., Wang, Z., Gorodetski, B., & Geschwind, J.-F. H. (2014) · Radiology · doi:10.1148/radiol.14141180 · Cited by 57
Yang, T., Zhang, J., Lu, J., Yang, L., Yang, G.-S., Wu, M., & Yu, W. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0935-3 · Cited by 57
Ciuleanu, T., Bazin, I. S., Lungulescu, D., Miron, L., Bondarenko, I., Deptała, A., Rodriguez‐Torres, M., Giantonio, B. J., Fox, N. L., Wissel, P. S., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw004 · Cited by 57
Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver
Wörns, M., Boßlet, T., Victor, A., Koch, S., Hoppe‐Lotichius, M., Heise, M., Hansen, T., Pitton, M. B., Niederle, I. M., Schuchmann, M., et al. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.677952 · Cited by 57
Cai, J., Li, B., Zhu, Y., Fang, X., Zhu, M., Wang, M., Liu, S., Jiang, X., Zheng, J., Zhang, X., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.014 · Cited by 57
Rizell, M., Eilard, M. S., Andersson, M., Andersson, B. A., Karlsson‐Parra, A., & Suenaert, P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00019 · Cited by 57
Affonso, B. B., Galastri, F. L., da Motta-Leal-Filho, J. M., Nasser, F., Falsarella, P. M., Cavalcante, R. N., de Almeida, M. D., Felga, G. E. G., Valle, L. G. M., & Wolosker, N. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i37.5687 · Cited by 57
Pan, Y., Chen, J.-C., Fang, A., Wang, X., Chen, J., Wang, J., He, W. A., Fu, Y., Xu, L., Chen, M., et al. (2019) · 癌症:英文版 · doi:10.1186/s40880-019-0404-6 · Cited by 57
Hepatocellular carcinoma: epidemiology, biology, diagnosis, and therapies
Gomes, M. A., Priolli, D. G., Tralhão, J. G., & Botelho, M. F. (2013) · Revista da Associação Médica Brasileira (English Edition) · doi:10.1016/s2255-4823(13)70511-3 · Cited by 57
Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma
Su, Z., Zhao, J., Rong, Z., Geng, W., Wu, Y., & Qin, C. (2014) · Diagnostic Pathology · doi:10.1186/1746-1596-9-47 · Cited by 56
Govalan, R., Lauzon, M., Luu, M., Ahn, J. C., Kosari, K., Todo, T., Kim, I. K., Noureddin, M., Kuo, A., Walid, A. S., et al. (2021) · Liver Cancer · doi:10.1159/000515554 · Cited by 52
Cachexia is Prevalent in Patients With Hepatocellular Carcinoma and Associated With Worse Prognosis
Rich, N. E., Phen, S., Desai, N., Mittal, S., Yopp, A. C., Yang, J. D., Marrero, J. A., Iyengar, P., Infante, R. E., & Singal, A. G. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.09.022 · Cited by 56
Higashi, T., Hatano, E., Ikai, I., Nishii, R., Nakamoto, Y., Ishizu, K., Suga, T., Kawashima, H., Togashi, K., Seo, S., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1284-9 · Cited by 56
Farinati, F., Vanin, V., Giacomin, A., Pozzan, C., Cillo, U., Vitale, A., Nolfo, A. M. D., Poggio, P. D., Benvegnù, L., Rapaccini, G., et al. (2014) · Liver International · doi:10.1111/liv.12649 · Cited by 56
Na, S. J., Oh, J. K., Hyun, S. H., Lee, J. W., Hong, I. K., Song, B., Kim, T. S., Eo, J. S., Lee, S. W., Yoo, I. R., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.182022 · Cited by 56
Yang, H., Seon, J., Sung, P. S., Oh, J. S., Lee, H. L., Jang, B., Chun, H. J., Jang, J. W., Bae, S. H., Choi, J. Y., et al. (2017) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2017.07.021 · Cited by 56
Guo, H., Wu, T., Lu, Q., Li, M., Guo, J.-Y., Shen, Y. L., Wu, Z., Nan, K., Lv, Y., & Zhang, X. (2018) · Cancer Management and Research · doi:10.2147/cmar.s152707 · Cited by 56
Tanrıverdi, Ö. (2014) · Medical Oncology · doi:10.1007/s12032-014-0282-3 · Cited by 56
Liu, T.-A., Jan, Y., Ko, B., Chen, S.-C., Liang, S.-M., Hung, Y.-L., Hsu, C., Shen, T., Lee, Y.-M., Chen, P., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.08.010 · Cited by 56
Faloppi, L., Scartozzi, M., Maccaroni, E., Paolo, M. D. P., Berardi, R., Prete, M. D., & Cascinu, S. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.08.001 · Cited by 55
Interventional treatment for unresectable hepatocellular carcinoma
Murata, S., Mine, T., Sugihara, F., Yasui, D., Yamaguchi, H., Ueda, T., Onozawa, S., & Kumita, S.-I. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i37.13453 · Cited by 55
Bang, H., Ha, S. Y., Hwang, S. H., & Park, C.-K. (2015) · Cancer Research and Treatment · doi:10.4143/crt.2014.124 · Cited by 55
O’Neil, B. H., & Venook, A. P. (2007) · The Oncologist · doi:10.1634/theoncologist.12-12-1425 · Cited by 55
Hepatobiliary Tumors: Update on Diagnosis and Management
Kabbach, G., Assi, H., Bolotin, G., Schuster, M., Lee, H. J., & Tadros, M. S. (2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00012 · Cited by 55
Liu, W., Wang, K., Bao, Q., Sun, Y., & Xing, B. (2016) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-0811-y · Cited by 55
Percutaneous ablation of pancreatic cancer
D’Onofrio, M., Ciaravino, V., Robertis, R. D., Barbi, E., Salvia, R., Girelli, R., Paiella, S., Gasparini, C., Cardobi, N., & Bassi, C. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i44.9661 · Cited by 55
The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Luo, F., Li, M., Ding, J., & Zheng, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.635731 · Cited by 55
Hiraoka, A., Kumada, T., Tada, T., Hirooka, M., Kariyama, K., Tani, J., Atsukawa, M., Takaguchi, K., Itobayashi, E., Fukunishi, S., et al. (2021) · Hepatology Research · doi:10.1111/hepr.13734 · Cited by 56
Liver transplantation for hepatocellular carcinoma: Are the Milan criteria still valid?
Schwartz, M., D’Amico, F., Vitale, A., Emre, S., & Cillo, U. (2007) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2007.07.208 · Cited by 55
Omagari, K., Honda, S., Kadokawa, Y., Isomoto, H., Takeshima, F., HAYASHIDA, K., Mizuta, Y., Murata, I., & Kohno, S. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03350.x · Cited by 55
Reig, M., Forner, A., Avila, M. A., Ayuso, C., Mínguez, B., Varela, M., Bilbao, I., Bilbao, J. I., Burrel, M., Bustamante, J., et al. (2021) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2020.09.004 · Cited by 56
Self-citationMarelli, L., Grasso, A., Pleguezuelo, M., Martines, H., Stigliano, R., Dhillon, A. P., Patch, D., Davidson, B. R., Sharma, D., Rolles, K., et al. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0128-3 · Cited by 54
Abdelaziz, A. O., Elbaz, T. M., Shousha, H. I., Ibrahim, M. M., Elshazli, M., Abdelmaksoud, A., Aziz, O. A., Zaki, H. A., Elattar, I. A., & Nabil, M. M. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.9.3915 · Cited by 54
TACE performed in patients with a single nodule of Hepatocellular Carcinoma
Terzi, E., Piscaglia, F., Forlani, L., Mosconi, C., Renzulli, M., Bolondi, L., & Golfieri, R. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-601 · Cited by 54
A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels
Carr, B. I., & Guerra, V. (2016) · Oncology · doi:10.1159/000444394 · Cited by 54
Cariani, E., Pilli, M., Barili, V., Porro, E., Biasini, E., Olivani, A., Valle, R. D., Trenti, T., Ferrari, C. I., & Missale, G. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1154249 · Cited by 54
Coppola, N., Onorato, L., Iodice, V., Starace, M., Minichini, C., Farella, N., Liorre, G., Filippini, P., Sagnelli, E., & de Stefano, G. (2016) · Oncotarget · doi:10.18632/oncotarget.10909 · Cited by 54
An, J., Lee, K. S., Kim, K. M., Park, D. H., Lee, S. S., Lee, D., Shim, J. H., Lim, Y., Lee, H. C., Chung, Y., et al. (2017) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2016.0088 · Cited by 54
Zhou, G., Han, J. S., Sun, J., Zhang, Y., Zhou, T., Nie, C., Zhu, T., Chen, S.-Q., Wang, B., Yu, Z., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4566-4 · Cited by 54
Chan, K., Lee, C., Wu, T.-J., Chou, H., Yu, M., Lee, W., & Chen, M. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1367-1 · Cited by 54
Chromogranin A levels in chronic liver disease and hepatocellular carcinoma
Massironi, S., Fraquelli, M., Paggi, S., Sangiovanni, A., Conte, D., Sciola, V., Ciafardini, C., Colombo, M., & PERACCHI, M. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.05.002 · Cited by 54
Treatment and prognostic factors in patients with hepatocellular carcinoma
Martins, A., Cortez‐Pinto, H., Marques-Vidal, P. M., Mendes, N., Silva, S. G., Fatela, N., Gloria, H. C., Marinho, R. T., Távora, I., Ramalho, F. J., et al. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.001285.x · Cited by 54
Rimini, M., Shimose, S., Lonardi, S., Tada, T., Masi, G., Iwamoto, H., Lai, E., Burgio, V., Hiraoka, A., Ishikawa, T., et al. (2021) · Hepatology Research · doi:10.1111/hepr.13718 · Cited by 53
Kwak, H. A., Park, J., Nam, B., Yu, A., Woo, S. M., Kim, T. H., Kim, S. H., Koh, Y. H., Kim, H. B., Park, S., et al. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12470 · Cited by 53
microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma
Yu, F., Lu, Z., Chen, B., Dong, P., & Zheng, J. (2015) · Diagnostic Pathology · doi:10.1186/s13000-015-0369-y · Cited by 53
BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A
Jung, Y. K., Jung, C. H., Seo, Y. S., Kim, J. H., Kim, T. H., Yoo, Y. J., Kang, S. H., Yim, S. Y., Suh, S. J., An, H., et al. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13152 · Cited by 53
Liver resection for HCC: Patient's selection and controversial scenarios
Cauchy, F., Soubrane, O., & Belghiti, J. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.08.013 · Cited by 53
Lin, D., Zhang, Q., Li, X., Ye, Q.-W., Lin, F., & Li, L. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0868-x · Cited by 53
Schöniger–Hekele, M., Hänel, S., Wrba, F., & Müller, C. (2005) · Liver International · doi:10.1111/j.1478-3231.2004.0997.x · Cited by 53
Huo, T., Lin, H., Huang, Y., Wu, J., Chiang, J., Lee, P.-C., & Lee, S. (2006) · Cancer · doi:10.1002/cncr.21972 · Cited by 53
Hepatocellular Carcinoma and Liver Transplantation: State of the Art
Mancuso, A., & Perricone, G. (2014) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2014.00013 · Cited by 53
Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma
El‐Shal, A. S., Zidan, H. E., Rashad, N. M., & Wadea, F. M. (2017) · Cytokine · doi:10.1016/j.cyto.2017.03.006 · Cited by 53
Müller, L., Stoehr, F., Mähringer‐Kunz, A., Hähn, F., Weinmann, A., & Kloeckner, R. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s285735 · Cited by 53
Hepatocellular carcinoma: an update.
Blum, H. E., & Spangenberg, H. C. (2007) · PubMed · Cited by 53
HCC Heterogeneity: Molecular Pathogenesis and Clinical Implications
Fransvea, E., Paradiso, A., Antonaci, S., & Giannelli, G. (2009) · Analytical Cellular Pathology · doi:10.1155/2009/134921 · Cited by 53
Influence of Recent Advances in Medical Management on Clinical Outcomes of Cirrhosis
Talwalkar, J. A., & Kamath, P. S. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.11.1501 · Cited by 53
He, Q., Yang, J., & Jin, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869993 · Cited by 52
Reichl, P., Fang, M., Starlinger, P. P., Staufer, K., Nenutil, R., Müller, P., Greplová, K., Valík, D., Dooley, S., Brostjan, C., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29394 · Cited by 52
Dhanasekaran, R., Kooby, D. A., Staley, C. A., Kauh, J. S. W., Khanna, V., & Kim, H. S. (2010) · HPB · doi:10.1111/j.1477-2574.2009.00138.x · Cited by 52
Zhou, L., Fu, J., Lu, Y., Fu, B., Wang, C., An, L., Wang, X.-Z., Zeng, Z., Zhou, C., Yang, Y., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0243-3 · Cited by 52
Ronzoni, A., Artioli, D., Scardina, R., Battistig, L., Minola, E., Sironi, S., & Vanzulli, A. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.07.2040 · Cited by 52
Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma
Altadill, A., Rodríguez, M., González, L. O., Junquera, S., Corte-Torres, M. D., González-Diéguez, M. L., Linares, A., Barbón, E., Fresno-Forcelledo, M. F., Rodrigo, L., et al. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.01.016 · Cited by 52
Asvadi, N. H., Anvari, A., Uppot, R. N., Thabet, A., Zhu, A. X., & Arellano, R. S. (2016) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2016.01.010 · Cited by 52
Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma
Jiang, L., Hou, Y., Cai, X.-B., & Liu, B. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i15.4034 · Cited by 52
Li, X., Wang, Y., Ye, X., & Liang, P. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.635243 · Cited by 53
Borgia, M., Bo, M. D., & Toffoli, G. (2021) · Cancers · doi:10.3390/cancers13174387 · Cited by 53
Yang, Y., Zhou, Y., Zhou, C., & Ma, X. (2021) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2021.11.120 · Cited by 52
Ong, H., Tan, P. K., Wang, S. M., Low, D. T. H., Ooi, L. L., & Hui, K. M. (2011) · Cancer Gene Therapy · doi:10.1038/cgt.2011.5 · Cited by 52
Francica, G., Saviano, A., de Sio, I., Matthaeis, N. D., Brunello, F. G., Cantamessa, A., Giorgio, A., Scognamiglio, U., Fornari, F., Giangregorio, F., et al. (2012) · Digestive and Liver Disease · doi:10.1016/j.dld.2012.10.022 · Cited by 52
Mizukoshi, E., Nakagawa, H., Tamai, T., Kitahara, M., Fushimi, K., Nio, K., Terashima, T., Iida, N., Arai, K., Yamashita, T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30861-z · Cited by 51
Liang, J., Ping, X.-O., Tseng, Y., Huang, G., Lai, F., & Yang, P. (2014) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2014.09.001 · Cited by 51
Kaseb, A. O., Hassan, M. M., Lin, E. H., Xiao, L., Kumar, V. S., Pathak, P., Lozano, R. D., Rashid, A., Abbruzzese, J. L., & Morris, J. S. (2010) · Cancer · doi:10.1002/cncr.25791 · Cited by 51
Circulating Tumor Cells Measurements in Hepatocellular Carcinoma
Chiappini, F. (2012) · International Journal of Hepatology · doi:10.1155/2012/684802 · Cited by 51
Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Kis, B., El-Haddad, G. E., Sheth, R. A., Parikh, N. S., Ganguli, S., Shyn, P. B., Choi, J., & Brown, K. T. (2017) · Cancer Control · doi:10.1177/1073274817729244 · Cited by 51
Cai, X., Chen, Z., Chen, J., Ma, X., Bai, M., Wang, T., Chen, X., Wu, D., Li, W., Li, X., et al. (2017) · Journal of Cancer · doi:10.7150/jca.21799 · Cited by 51
Koh, Y. X., Tan, H. L., Lye, W. K., Kam, J. H., Chiow, A. K. H., Tan, S. S., Choo, S. P., Chung, A. Y. F., & Goh, B. K. P. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i6.433 · Cited by 51
Sandro, S. D., Bagnardi, V., Najjar, M., Buscemi, V., Lauterio, A., Carlis, R. D., Danieli, M., Pinotti, E., Benuzzi, L., & Carlis, L. G. D. (2018) · Surgical Oncology · doi:10.1016/j.suronc.2018.10.001 · Cited by 51
Interaction of Gender and Hepatitis C in Risk of Chronic Renal Failure After Liver Transplantation
Ip, S., Hussaini, T., Daulat, A., Partovi, N., Erb, S. R., Yoshida, E. M., & Marquez, V. (2017) · Annals of Hepatology · doi:10.5604/16652681.1231583 · Cited by 51
Mähringer‐Kunz, A., Wagner, F., Hähn, F., Weinmann, A., Brodehl, S., Schotten, S., Hinrichs, J. B., Düber, C., Galle, P. R., dos Santos, D. P., et al. (2020) · Liver International · doi:10.1111/liv.14380 · Cited by 51
Schullian, P., Johnston, E. W., Putzer, D., Eberle, G., Laimer, G., & Bale, R. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-58383-y · Cited by 51
Metadata
- Authors
- Llovet, J., Brú, C., & Bruix, J.
- Affiliations
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 1999
- Volume
- 19
- Issue
- 03
- Pages
- 329-338
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2147172608
- Cited by
- 3,805
- References
- 0
- Citations by year
- 2026: 70 · 2025: 117 · 2024: 162 · 2023: 211 · 2022: 269 · 2021: 280 · 2020: 279 · 2019: 215 · 2018: 206 · 2017: 218 · 2016: 216 · 2015: 220 · 2014: 219 · 2013: 163 · 2012: 154
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- hepatocellular carcinoma, prognosis, tumor staging, radical treatment, liver transplantation, hepatectomy, percutaneous treatment, vascular invasion, extrahepatic spread, palliative care, Okuda staging
- MeSH terms
- Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Prognosis, Survival Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.